Li, Ning
Liu, Xuenan
Wang, Hao
Duan, Yingling
Zhang, Yu
Zhou, Ping
Dai, Haofu
Lan, Tian
Funding for this research was provided by:
National Natural Science Foundation of China (82070590, 82373930, 32171824)
Key R&D Plan of Science and Technology Department of Sichuan Province (2022YFS0149)
Health Commission of Sichuan Province Technology Projects in 2023,Clinical Research Projects (23LCYJ015)
Major Technology Project of Hainan Province (ZDKJ2021031)
China Agriculture Research System of MOF and MARA (CARS-21)
Article History
Received: 23 December 2023
Accepted: 8 March 2024
First Online: 23 April 2024
Declarations
:
: The experimental protocols and procedures were approved on February 4, 2022, by the Ethics Committee for Animal Experiments of Guangdong Pharmaceutical University, in accordance with the Guidelines for the Care and Use of Laboratory Animals (approval code: gdpulacspf 2017619).
: All authors consent to the publication of this work in Chinese Medicine.
: The authors declare no competing financial interests.